Non prescription Drugs

Non-Prescription Drugs Market Outlook

The global non-prescription drugs market is projected to reach approximately USD 150 billion by 2035, with a compound annual growth rate (CAGR) of 6.5% during the forecast period from 2025 to 2035. This growth can be attributed to several key factors, including the increasing self-medication trend among consumers, the rising prevalence of chronic diseases, and growing awareness of over-the-counter (OTC) drugs. Additionally, the expansion of retail pharmacies and online platforms has significantly increased accessibility to these products, further propelling market growth. Furthermore, the aging population is driving the demand for vitamins and dietary supplements, which has become a significant segment within the non-prescription drugs market. The ongoing innovations and product developments in the pharmaceutical industry are also creating new opportunities for market expansion.

Growth Factor of the Market

The non-prescription drugs market is experiencing substantial growth driven by a variety of factors. One of the primary growth factors is the increasing consumer preference for self-medication, as individuals seek to manage minor ailments without the need for a healthcare professional's intervention. With the rise of chronic diseases such as diabetes and hypertension, there is a growing reliance on OTC drugs for symptom management and overall health maintenance. Moreover, the convenience of purchasing non-prescription drugs from pharmacies and online platforms has made them more accessible to consumers, thereby increasing sales. The growing trend of preventive healthcare and wellness has further fueled demand for dietary supplements, such as vitamins and minerals, contributing to the market's expansion. Additionally, the COVID-19 pandemic has heightened awareness around health and wellness, leading to a surge in the consumption of non-prescription drugs. These factors collectively create a robust environment for continuous growth in the non-prescription drugs market.

Key Highlights of the Market

• The non-prescription drugs market is expected to grow at a CAGR of 6.5% from 2025 to 2035.
• Increasing self-medication among consumers is a significant driver of market growth.
• The rise of e-commerce platforms has enhanced the accessibility of OTC products.
• Chronic disease prevalence is leading to higher demand for non-prescription medications.
• Growing awareness of health and wellness is boosting the dietary supplement segment.

By Product Type

Analgesics:

Analgesics constitute a substantial segment within the non-prescription drugs market, primarily due to their widespread use for pain relief. They are commonly utilized to alleviate mild to moderate pain arising from various conditions, such as headaches, muscle aches, arthritis, and post-surgical discomfort. The availability of both non-steroidal anti-inflammatory drugs (NSAIDs) and acetaminophen in OTC formulations makes analgesics highly accessible to consumers. Continued innovation in formulation, including the introduction of extended-release options and combination products, further enhances their appeal. As awareness of pain management continues to grow, coupled with the increasing incidence of chronic pain conditions, the analgesics segment is anticipated to witness robust growth in the coming years.

Cold and Flu Remedies:

Cold and flu remedies represent another significant category of non-prescription drugs, catering to a large market of consumers seeking relief from common viral infections. These remedies typically include decongestants, antihistamines, cough suppressants, and expectorants. The convenience of accessing these products without a prescription has contributed to their popularity, especially during peak flu seasons. The ongoing development of combination therapies that target multiple symptoms simultaneously is expected to drive further growth in this segment. Seasonal variations and increasing public health awareness regarding influenza and respiratory infections underscore the importance of cold and flu remedies in the non-prescription drugs market.

Digestive Remedies:

Digestive remedies are increasingly becoming a focal point in the non-prescription drugs market, addressing a range of gastrointestinal issues such as indigestion, acid reflux, and constipation. Products such as antacids, proton-pump inhibitors, and laxatives fall under this segment, and their availability over the counter has made them a go-to choice for consumers experiencing digestive discomfort. Rising consumer awareness regarding gut health and the increasing prevalence of digestive disorders are propelling the demand for these products. Furthermore, the trend towards natural and herbal remedies is influencing product development, leading to the emergence of new formulations aimed at providing effective digestive relief.

Vitamins and Minerals:

Vitamins and minerals have emerged as a prominent segment in the non-prescription drugs market, reflecting a growing consumer focus on preventive healthcare and overall wellness. The increasing popularity of dietary supplements can be attributed to heightened awareness regarding nutritional deficiencies and the role of vitamins and minerals in promoting health. Leading manufacturers are continually innovating to create targeted formulations that address specific health needs, such as immune support, bone health, and energy enhancement. The expansion of product offerings, including gummies, powders, and liquid supplements, is attracting a diverse consumer base. As more individuals prioritize health and wellness, the vitamins and minerals segment is poised for significant growth.

Sleep Aids:

Sleep aids represent a crucial component of the non-prescription drugs market, as sleep disorders have become increasingly prevalent in today's fast-paced society. The demand for over-the-counter sleep aids, including melatonin and antihistamines, has surged as consumers seek solutions for issues such as insomnia, jet lag, and general sleep disturbances. This segment is experiencing innovation with the introduction of natural and herbal sleep products, catering to consumers who prefer non-pharmaceutical options. The focus on holistic wellness and stress management has also contributed to the growth of sleep aids, as individuals seek to improve sleep quality as part of a broader health strategy. The increasing recognition of the importance of sleep in overall health and well-being is expected to drive continued expansion within this segment.

By Application

OTC Pharmaceuticals:

The OTC pharmaceuticals segment is a core aspect of the non-prescription drugs market, encompassing a wide range of medications that consumers can purchase without a prescription. This segment includes products aimed at treating various conditions, such as pain relief, allergy management, and digestive issues. The accessibility of these medications has significantly contributed to their growth, particularly as consumers become more proactive in managing their health. Furthermore, the regulatory environment surrounding OTC drugs continues to evolve, allowing for a broader range of products to be available over the counter. With increasing consumer awareness of health issues and a shift toward self-care, the OTC pharmaceuticals segment is expected to continue expanding in the coming years.

Dietary Supplements:

Dietary supplements have gained significant traction within the non-prescription drugs market, driven by a growing emphasis on preventive healthcare and wellness. This segment encompasses vitamins, minerals, herbal products, and sports nutrition supplements, catering to a diverse array of consumer needs. The demand for dietary supplements is fueled by rising health consciousness and the desire to enhance overall well-being. Additionally, the increasing prevalence of lifestyle-related health issues has led individuals to seek out supplements that can support their health goals. As the market continues to innovate and expand with new formulations and delivery methods, dietary supplements are positioned for robust growth within the non-prescription drugs market.

By Distribution Channel

Pharmacies:

Pharmacies serve as a primary distribution channel for non-prescription drugs, offering a wide selection of OTC medications and dietary supplements. The convenience of local pharmacies allows consumers to access essential health products quickly, contributing to the growth of this channel. Many pharmacies are also expanding their service offerings, including consultations and health screenings, further elevating their role in the healthcare landscape. The presence of licensed pharmacists enables customers to receive guidance on product selection, enhancing consumer confidence in their purchases. With an increasing number of pharmacies adopting innovative retail strategies, such as loyalty programs and personalized marketing, this distribution channel is expected to maintain a significant share of the non-prescription drugs market.

Supermarkets/Hypermarkets:

Supermarkets and hypermarkets have emerged as key players in the distribution of non-prescription drugs, providing consumers with a convenient one-stop shopping experience. These large retail stores often feature dedicated health and wellness sections that include a wide range of OTC products, making them highly accessible to shoppers. The competitive pricing and promotional offers available in supermarkets and hypermarkets further attract consumers, driving sales in this channel. As shopping habits evolve, major retailers are increasingly focusing on creating a seamless shopping experience that integrates both physical and online channels, ensuring that they remain a vital distribution option for non-prescription drugs.

Online Retail:

The online retail channel has seen explosive growth in the distribution of non-prescription drugs, driven by the convenience and accessibility of e-commerce. Consumers can easily browse and purchase a variety of OTC medications and dietary supplements from the comfort of their homes, allowing for greater privacy and discretion. The pandemic has accelerated the trend toward online shopping, as more individuals have turned to e-commerce platforms for their health needs. Additionally, online retailers often provide comprehensive product information and customer reviews, helping consumers make informed choices. As technology continues to evolve and logistics improve, the online retail channel is expected to capture an increasingly larger share of the non-prescription drugs market.

Convenience Stores:

Convenience stores play a significant role in the distribution of non-prescription drugs, particularly for consumers seeking quick and easy access to essential health products. These stores typically offer a limited yet essential selection of OTC medications and dietary supplements, catering to customers in need of immediate relief for minor ailments. The strategic locations and extended hours of operation of convenience stores enhance their appeal, making them a popular choice for consumers on the go. As more consumers prioritize convenience and speed in their shopping experiences, convenience stores are poised to remain a viable distribution channel in the non-prescription drugs market.

By Ingredient Type

Acetaminophen:

Acetaminophen is one of the most widely used active ingredients in non-prescription drugs, primarily known for its efficacy in pain relief and fever reduction. Commonly found in analgesics, acetaminophen is favored for its relatively mild side effect profile compared to other pain relievers, such as NSAIDs. This ingredient is often used in combination with other active ingredients to enhance therapeutic effects, making it a versatile component in many OTC products. The ongoing consumer demand for effective and safe pain relief options continues to support the growth of acetaminophen-based products in the non-prescription drugs market. As more consumers seek non-invasive solutions for managing pain and discomfort, acetaminophen's popularity is expected to persist.

Ibuprofen:

Ibuprofen is another key ingredient in the non-prescription drugs market, widely recognized for its anti-inflammatory, analgesic, and antipyretic properties. Often utilized for the treatment of pain, swelling, and fever, ibuprofen is a staple in many OTC pain relief formulations. The ingredient's effectiveness and rapid onset of action make it a popular choice among consumers seeking relief for headaches, menstrual cramps, and other common pain conditions. Due to its well-established safety profile and availability in various formulations, including tablets, liquids, and topical applications, ibuprofen continues to be a significant driver of growth within the non-prescription drugs market.

Diphenhydramine:

Diphenhydramine is a widely used antihistamine found in many non-prescription drugs, particularly those targeting allergy symptoms and sleep aids. Known for its sedative properties, diphenhydramine is commonly included in formulations designed to relieve symptoms associated with hay fever, colds, and insomnia. The ingredient's dual-action capability appeals to consumers seeking both allergy relief and sleep support, thereby broadening its market appeal. As awareness of allergy management and the importance of sleep increases, the demand for diphenhydramine-containing products is expected to grow, further solidifying its role in the non-prescription drugs market.

Vitamin C:

Vitamin C is a vital ingredient in dietary supplements and OTC products, renowned for its immune-boosting properties. As consumers increasingly prioritize preventive healthcare, the demand for vitamin C-rich products has surged. It is often included in formulations aimed at enhancing overall health and wellness, especially during cold and flu seasons. The ingredient is also popular for its potential benefits in skin health and collagen synthesis, attracting a diverse consumer base. With the ongoing trend toward health consciousness, the market for vitamin C supplements and related products is poised for continued growth within the non-prescription drugs sector.

Calcium:

Calcium is an essential mineral widely recognized for its role in promoting bone health and overall bodily functions. In the non-prescription drugs market, calcium is primarily found in dietary supplements aimed at addressing deficiencies and supporting bone density. The increasing aging population and the rising prevalence of osteoporosis are driving demand for calcium supplements, making it a crucial ingredient in this market segment. Additionally, calcium is often combined with vitamin D to enhance absorption, further increasing its appeal to consumers seeking comprehensive health solutions. As awareness of the importance of bone health continues to grow, calcium-based products are expected to maintain a significant presence in the non-prescription drugs market.

By Region

The regional analysis of the non-prescription drugs market reveals significant disparities in market size and growth potential across different areas. North America currently dominates the market, accounting for approximately 40% of the global share, fueled by high consumer awareness, robust healthcare infrastructure, and a strong retail pharmacy network. The region is projected to maintain a CAGR of 6% through 2035, driven by the increasing emphasis on preventive healthcare and self-medication trends. Europe follows closely, with a market share of around 30%, as consumers increasingly turn to OTC products for managing health conditions. The expansion of e-commerce and retail pharmacies in European countries is expected to further bolster growth in this region.

In the Asia Pacific region, the non-prescription drugs market is witnessing rapid growth, attributed to rising disposable incomes, changing lifestyles, and increased awareness regarding health and wellness. This region is expected to experience the highest CAGR of 7% during the forecast period, as consumers increasingly adopt self-medication practices. Additionally, the Latin American market is projected to grow steadily, driven by an increasing focus on preventive healthcare and wellness. The Middle East & Africa, while currently holding a smaller market share, shows potential for future growth as healthcare access improves and consumer awareness of non-prescription drugs expands. The diverse regional dynamics illustrate the multifaceted opportunities and challenges within the global non-prescription drugs market.

Opportunities

The non-prescription drugs market is poised for numerous opportunities in the coming years, primarily driven by evolving consumer preferences and advancements in technology. The increasing trend of self-medication presents a significant opportunity for manufacturers to develop innovative and effective OTC products that cater to the specific needs of consumers. As individuals seek to take control of their health management, companies can leverage this trend by introducing targeted formulations that address common ailments, thereby enhancing their market positioning. Furthermore, the rise of e-commerce has opened up new avenues for distribution, allowing companies to reach a wider audience and streamline the purchasing experience. By investing in digital marketing strategies and online retail partnerships, manufacturers can capitalize on the growing trend of online shopping, ultimately driving sales and brand loyalty.

Another noteworthy opportunity within the non-prescription drugs market lies in the increasing focus on preventive healthcare and wellness. As consumers become more health-conscious, there is a growing demand for dietary supplements and natural remedies that promote overall well-being. This shift presents a unique chance for manufacturers to develop products that align with consumer preferences for clean labels, organic ingredients, and sustainable sourcing practices. Additionally, the development of personalized health solutions, supported by advancements in technology and data analytics, can enable companies to tailor their offerings to meet individual health needs, further strengthening their competitive advantage. By staying attuned to consumer trends and preferences, companies in the non-prescription drugs market can position themselves to seize these emerging opportunities effectively.

Threats

Despite the promising growth prospects in the non-prescription drugs market, several threats could impede progress. One major concern is the increasing competition from counterfeit products, which can undermine consumer trust and safety. The proliferation of fake or substandard OTC medications poses a significant risk to both consumers and legitimate manufacturers, as it can lead to adverse health effects and tarnish brand reputations. Regulatory bodies are working to combat this issue, but the challenge remains significant, particularly with the rise of online sales channels that can facilitate the distribution of counterfeit drugs. Additionally, changing regulations and compliance requirements can create hurdles for manufacturers, as they must navigate differing standards across regions and adapt their product lines accordingly.

Another threat to the non-prescription drugs market is the potential impact of economic fluctuations and changing consumer spending habits. During economic downturns, consumers may prioritize essential goods and services, leading to a decline in discretionary spending on health and wellness products. This shift could negatively affect sales in the non-prescription drugs market, particularly for higher-priced or premium offerings. Furthermore, the potential for increased regulations on the advertising and marketing of non-prescription drugs may limit promotional activities and potentially hinder market growth. Companies must remain vigilant and adaptable to these threats to ensure sustained success in the evolving landscape of the non-prescription drugs market.

Competitor Outlook

• Johnson & Johnson
• Pfizer Inc.
• Procter & Gamble Co.
• GlaxoSmithKline PLC
• Bayer AG
• Novartis AG
• Reckitt Benckiser Group PLC
• Sanofi S.A.
• AbbVie Inc.
• Church & Dwight Co., Inc.
• Amgen Inc.
• Herbalife Nutrition Ltd.
• GNC Holdings, Inc.
• Nature's Way Products, LLC
• Vitamin Shoppe, Inc.

The competitive landscape of the non-prescription drugs market is characterized by the presence of numerous established players and emerging companies striving to capture market share. Major companies such as Johnson & Johnson and Pfizer Inc. maintain a strong foothold in the market with their extensive portfolios of OTC pharmaceuticals and dietary supplements. These companies leverage their brand recognition, significant research and development capabilities, and established distribution networks to remain competitive. Strategic collaborations, mergers, and acquisitions are common among industry players as they seek to expand their product offerings and enhance their market presence. Additionally, the growing trend toward self-medication is prompting companies to invest in innovative product development to cater to evolving consumer needs.

Emerging companies are also making their mark in the non-prescription drugs market by focusing on niche segments and offering unique product formulations. For instance, companies like Herbalife Nutrition Ltd. and Nature's Way Products, LLC, capitalize on the increasing demand for natural and herbal dietary supplements. Their emphasis on clean ingredients, sustainability, and wellness aligns with shifting consumer preferences, allowing them to capture a loyal customer base. Moreover, online-first brands are gaining traction as e-commerce continues to reshape the retail landscape, providing additional competition to traditional manufacturers. These emerging competitors are focused on leveraging digital marketing strategies and direct-to-consumer sales models to optimize their market reach.

As the landscape evolves, key players such as GlaxoSmithKline PLC and Reckitt Benckiser Group PLC are also adapting their strategies to stay ahead of the competition. They are increasingly focusing on innovation, product differentiation, and consumer engagement to maintain their market leadership. By investing in research and development, these companies are enhancing their product lines with new formulations that address specific health concerns, such as immune support and stress management. Additionally, the growing emphasis on health and wellness is prompting established manufacturers to adopt a more consumer-centric approach, highlighting the importance of transparency, education, and evidence-based claims in their marketing efforts. The dynamic nature of the non-prescription drugs market necessitates continual adaptation and strategic foresight to navigate competitive pressures and seize emerging opportunities.

• 1 Appendix

  • 1.1 List of Tables
  • 1.2 List of Figures

• 2 Introduction

  • 2.1 Market Definition
  • 2.2 Scope of the Report
  • 2.3 Study Assumptions
  • 2.4 Base Currency & Forecast Periods

• 3 Market Dynamics

  • 3.1 Market Growth Factors
  • 3.2 Economic & Global Events
  • 3.3 Innovation Trends
  • 3.4 Supply Chain Analysis

• 4 Consumer Behavior

  • 4.1 Market Trends
  • 4.2 Pricing Analysis
  • 4.3 Buyer Insights

• 5 Key Player Profiles

  • 5.1 Bayer AG
    • 5.1.1 Business Overview
    • 5.1.2 Products & Services
    • 5.1.3 Financials
    • 5.1.4 Recent Developments
    • 5.1.5 SWOT Analysis
  • 5.2 Amgen Inc.
    • 5.2.1 Business Overview
    • 5.2.2 Products & Services
    • 5.2.3 Financials
    • 5.2.4 Recent Developments
    • 5.2.5 SWOT Analysis
  • 5.3 AbbVie Inc.
    • 5.3.1 Business Overview
    • 5.3.2 Products & Services
    • 5.3.3 Financials
    • 5.3.4 Recent Developments
    • 5.3.5 SWOT Analysis
  • 5.4 Novartis AG
    • 5.4.1 Business Overview
    • 5.4.2 Products & Services
    • 5.4.3 Financials
    • 5.4.4 Recent Developments
    • 5.4.5 SWOT Analysis
  • 5.5 Pfizer Inc.
    • 5.5.1 Business Overview
    • 5.5.2 Products & Services
    • 5.5.3 Financials
    • 5.5.4 Recent Developments
    • 5.5.5 SWOT Analysis
  • 5.6 Sanofi S.A.
    • 5.6.1 Business Overview
    • 5.6.2 Products & Services
    • 5.6.3 Financials
    • 5.6.4 Recent Developments
    • 5.6.5 SWOT Analysis
  • 5.7 Johnson & Johnson
    • 5.7.1 Business Overview
    • 5.7.2 Products & Services
    • 5.7.3 Financials
    • 5.7.4 Recent Developments
    • 5.7.5 SWOT Analysis
  • 5.8 GNC Holdings, Inc.
    • 5.8.1 Business Overview
    • 5.8.2 Products & Services
    • 5.8.3 Financials
    • 5.8.4 Recent Developments
    • 5.8.5 SWOT Analysis
  • 5.9 GlaxoSmithKline PLC
    • 5.9.1 Business Overview
    • 5.9.2 Products & Services
    • 5.9.3 Financials
    • 5.9.4 Recent Developments
    • 5.9.5 SWOT Analysis
  • 5.10 Procter & Gamble Co.
    • 5.10.1 Business Overview
    • 5.10.2 Products & Services
    • 5.10.3 Financials
    • 5.10.4 Recent Developments
    • 5.10.5 SWOT Analysis
  • 5.11 Vitamin Shoppe, Inc.
    • 5.11.1 Business Overview
    • 5.11.2 Products & Services
    • 5.11.3 Financials
    • 5.11.4 Recent Developments
    • 5.11.5 SWOT Analysis
  • 5.12 Herbalife Nutrition Ltd.
    • 5.12.1 Business Overview
    • 5.12.2 Products & Services
    • 5.12.3 Financials
    • 5.12.4 Recent Developments
    • 5.12.5 SWOT Analysis
  • 5.13 Church & Dwight Co., Inc.
    • 5.13.1 Business Overview
    • 5.13.2 Products & Services
    • 5.13.3 Financials
    • 5.13.4 Recent Developments
    • 5.13.5 SWOT Analysis
  • 5.14 Nature's Way Products, LLC
    • 5.14.1 Business Overview
    • 5.14.2 Products & Services
    • 5.14.3 Financials
    • 5.14.4 Recent Developments
    • 5.14.5 SWOT Analysis
  • 5.15 Reckitt Benckiser Group PLC
    • 5.15.1 Business Overview
    • 5.15.2 Products & Services
    • 5.15.3 Financials
    • 5.15.4 Recent Developments
    • 5.15.5 SWOT Analysis

• 6 Market Segmentation

  • 6.1 Non prescription Drugs Market, By Product Type
    • 6.1.1 Analgesics
    • 6.1.2 Cold and Flu Remedies
    • 6.1.3 Digestive Remedies
    • 6.1.4 Vitamins and Minerals
    • 6.1.5 Sleep Aids
  • 6.2 Non prescription Drugs Market, By Ingredient Type
    • 6.2.1 Acetaminophen
    • 6.2.2 Ibuprofen
    • 6.2.3 Diphenhydramine
    • 6.2.4 Vitamin C
    • 6.2.5 Calcium
  • 6.3 Non prescription Drugs Market, By Distribution Channel
    • 6.3.1 Pharmacies
    • 6.3.2 Supermarkets/Hypermarkets
    • 6.3.3 Online Retail
    • 6.3.4 Convenience Stores

• 7 Competitive Analysis

  • 7.1 Key Player Comparison
  • 7.2 Market Share Analysis
  • 7.3 Investment Trends
  • 7.4 SWOT Analysis

• 8 Research Methodology

  • 8.1 Analysis Design
  • 8.2 Research Phases
  • 8.3 Study Timeline

• 9 Future Market Outlook

  • 9.1 Growth Forecast
  • 9.2 Market Evolution

• 10 Geographical Overview

  • 10.1 Europe - Market Analysis
    • 10.1.1 By Country
      • 10.1.1.1 UK
      • 10.1.1.2 France
      • 10.1.1.3 Germany
      • 10.1.1.4 Spain
      • 10.1.1.5 Italy
  • 10.2 Asia Pacific - Market Analysis
    • 10.2.1 By Country
      • 10.2.1.1 India
      • 10.2.1.2 China
      • 10.2.1.3 Japan
      • 10.2.1.4 South Korea
  • 10.3 Latin America - Market Analysis
    • 10.3.1 By Country
      • 10.3.1.1 Brazil
      • 10.3.1.2 Argentina
      • 10.3.1.3 Mexico
  • 10.4 North America - Market Analysis
    • 10.4.1 By Country
      • 10.4.1.1 USA
      • 10.4.1.2 Canada
  • 10.5 Middle East & Africa - Market Analysis
    • 10.5.1 By Country
      • 10.5.1.1 Middle East
      • 10.5.1.2 Africa
  • 10.6 Non prescription Drugs Market by Region

• 11 Global Economic Factors

  • 11.1 Inflation Impact
  • 11.2 Trade Policies

• 12 Technology & Innovation

  • 12.1 Emerging Technologies
  • 12.2 AI & Digital Trends
  • 12.3 Patent Research

• 13 Investment & Market Growth

  • 13.1 Funding Trends
  • 13.2 Future Market Projections

• 14 Market Overview & Key Insights

  • 14.1 Executive Summary
  • 14.2 Key Trends
  • 14.3 Market Challenges
  • 14.4 Regulatory Landscape

Segments Analyzed in the Report

The global Non prescription Drugs market is categorized based on

By Product Type

• Analgesics
• Cold and Flu Remedies
• Digestive Remedies
• Vitamins and Minerals
• Sleep Aids

By Distribution Channel

• Pharmacies
• Supermarkets/Hypermarkets
• Online Retail
• Convenience Stores

By Ingredient Type

• Acetaminophen
• Ibuprofen
• Diphenhydramine
• Vitamin C
• Calcium

By Region

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

Key Players

• Johnson & Johnson
• Pfizer Inc.
• Procter & Gamble Co.
• GlaxoSmithKline PLC
• Bayer AG
• Novartis AG
• Reckitt Benckiser Group PLC
• Sanofi S.A.
• AbbVie Inc.
• Church & Dwight Co., Inc.
• Amgen Inc.
• Herbalife Nutrition Ltd.
• GNC Holdings, Inc.
• Nature's Way Products, LLC
• Vitamin Shoppe, Inc.